Who is sponsoring NCT04659954?

NCT04659954 is sponsored by University Hospital, Toulouse.

What drugs are being tested in NCT04659954?

Interventions in NCT04659954: Application O'DIDE.

What condition does NCT04659954 study?

NCT04659954 studies Substance-Related Disorders, Personality Disorders.

Is NCT04659954 still recruiting?

NCT04659954 is currently completed. Last updated 19 December 2023.

Last reviewed 2023-12-19 · How we verify

NCT04659954: FA-O'DIDE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility and Acceptability Study of the "O'Dide" Application in People Suffering From an Addiction

Completed NA Last updated 19 December 2023

What this trial tests

NA trial testing Application O'DIDE in Substance-Related Disorders in 24 participants. Completed in 10 February 2023.

Timeline

7 January 2022

Primary endpoint
10 February 2023

10 February 2023

Quick facts

Lead sponsor	University Hospital, Toulouse
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	24
Start date	7 January 2022
Primary completion	10 February 2023
Estimated completion	10 February 2023
Sites	1 location across France

Drugs / interventions tested

Application O'DIDE

Conditions studied

Substance-Related Disorders — all drugs for Substance-Related Disorders →
Personality Disorders — all drugs for Personality Disorders →

Sponsor

University Hospital, Toulouse

Who can join

18 and older, any sex, with Substance-Related Disorders or Personality Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Substance Use Disorders (SUD) are associated with cognitive schemas that lead to care attrition and mistrust towards care. Considering this within SUD management, it is important to establish a confident relation between the patient and the care team to favorize acre observance. However, it demands an important availability of the healthcare team, allowing for frequent interactions at all times, including at night and during days off. With the present study, the investigator postulated that an application called Ô DIDE for Digital Interaction for Detoxification Engagement, that aims to help the caregivers maintaining a link with the patient in order to facilitate confidence in the relationship, could favorize care observance especially consumption report.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Acceptability of "DIDE", a mobile application designed at facilitating care adherence of patients with substance use disorder.
Stocker A, Navarro N, Schmitt L, Delagnes M, et al · · 2024 · PMID 39407238 · DOI 10.1186/s13722-024-00500-7

Verify or expand the search:

Other recruiting trials for Substance-Related Disorders

Currently open trials in the same condition.

NCT06676059 — SMART-r: Substance Monitoring and Active Relapse Tracking Repository · recruiting
NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting
NCT06387290 — Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits · Phase 3 · recruiting
NCT05763537 — Understanding the Role of Doulas in Supporting People With PMADs · NA · recruiting
NCT06685003 — Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families · NA · recruiting

Other University Hospital, Toulouse trials

Trials by the same sponsor.

NCT07497750 — Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver D · NA · not yet recruiting
NCT07507240 — The Benefits of a Care Pathway Combining Remote Monitoring and Support From a Nurse After a Change in Anti-epileptic Tre · NA · not yet recruiting
NCT07524088 — Contamination of Young Children Hair During Acute Cannabis Intoxication · NA · not yet recruiting
NCT07470580 — Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension · NA · not yet recruiting
NCT07423988 — Evaluation of Changes in Sleep Efficiency Among PIC DU MIDI Staff Between Nights Spent at Home and Nights Spent in the W · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04659954 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Toulouse
Last refreshed: 19 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04659954.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing